Echo-2
Neko Health AB · Decision date Sep 22, 2026
What did the FDA decide?
FDA recorded a substantially equivalent (SESE) decision for Echo-2, a 510(k) submitted by Neko Health AB of Danderyd, Sweden, under number K254240. The decision date is 22 September 2026; the application was received 29 December 2025. The device falls under regulation 870.2786, classification product code QOK, with subsequent product code DXR, and the regulation medical specialty and 510(k) review panel are both Cardiovascular. The public record lists the device classification name as hardware and software for optical camera-based measurement of heart rate and respiratory rate.
SESE means the submission was cleared to market as substantially equivalent; it is not a PMA approval. The record describes a traditional 510(k) that was not reviewed by a third party, is not a combination product, and has no authorized predetermined change control plan. The page does not state which components, software versions or changes were assessed, nor does it give indications for use, performance data or comparison devices. Those details would sit in the underlying 510(k) documents, which are not included here.
- Regulatory pathway
- 510(k) premarket notification
- Clinical specialty
- Cardiovascular
- Decision date
- Sep 22, 2026
FDA source record · MedtechLedger’s explanation describes the recorded change.
Regulatory record facts
- Identifier
- K254240
- Regulatory pathway
- 510(k) premarket notification
- Applicant
- Neko Health AB
- Product code
- QOK
- Decision code
- SESE
- Decision date
- Sep 22, 2026
- Source update
- Nov 9, 2026
- Original record
- Open FDA source record
About this medical device
FDA device category: Hardware And Software For Optical Camera-Based Measurement Of Heart Rate And Respiratory Rate.
- Applicant
- Neko Health AB
- Product code
- QOK
- FDA device class
- 2
FDA decision timeline
K254240 received
Application receipt date recorded by FDA.
K254240 · FDA decision
SESE
Related devices and submissions
Explore the linked device profile
No additional submissions with a verified PMA or product-code relationship are linked here.
Regulatory context
A 510(k) submission seeks a finding of substantial equivalence to a legally marketed device. A clearance and a PMA approval are different regulatory decisions.
Read our guide to FDA clearance and approval · FDA’s explanation of this pathway
Manufacturer intelligence
Neko Health AB
- Headquarters
- Not reported
- Brand website
- Not reported
- FDA applicant address
- Danderyd
Sources and methodology
- Original FDA record: K254240
- openFDA source data · Source release Nov 9, 2026 · Retrieved Nov 19, 2026
FDA fields and approval-order wording are presented as source information. MedtechLedger explanations are identified separately and describe the scope of the recorded decision. Indications from an original PMA are historical unless confirmed against subsequent labeling and supplements.
How we use FDA records